Inhaled corticosteroids for asthma: common clinical quandaries.
- 1 January 2003
- journal article
- review article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 40 (2) , 107-118
- https://doi.org/10.1081/jas-120017980
Abstract
This narrative review provides evidence-based explanations to some of the common clinical concerns regarding inhaled corticosteroids. Inhaled corticosteroids are the treatment of choice for a newly diagnosed asthmatic patient. Better results are obtained when treatment is initiated as soon as the diagnosis is made. Asthma control can be achieved and maintained in most patients with a low or moderate dose of inhaled corticosteroid administered in two daily doses. Longer duration of treatment provides more sustained benefits than treatment that is intermittent and for short periods of time. The clinical benefits can be observed within 24 hours of commencing treatment and may be more pronounced in patients with an eosinophilic bronchitis. Inhaled corticosteroids provide additional benefit when used in conjunction with prednisone in acute severe asthma. Low doses do not have clinically deleterious side effects on the bones, growth, eye, or hypothalamo-pituitary-adrenal-axis. However, they do not normalize lung function and prevent structural changes in the airway wall in all asthmatic patients.Keywords
This publication has 62 references indexed in Scilit:
- Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trialJournal of Allergy and Clinical Immunology, 2001
- Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals--a lesser benefit in femalesEuropean Respiratory Journal, 2000
- Inhaled corticosteroids, family history, and risk of glaucomaOphthalmology, 1999
- Sputum eosinophil count to assess compliance with corticosteroid therapy in asthmaJournal of Allergy and Clinical Immunology, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.Thorax, 1996
- Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.Thorax, 1995
- Beclomethasone given after the early asthmatic response inhibits the late response and the increased methacholine responsiveness and cromolyn does notJournal of Allergy and Clinical Immunology, 1993
- Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintainedJournal of Allergy and Clinical Immunology, 1991
- Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study.Thorax, 1988